None of us know what, if any, restrictions Gerald is under
None of us know what, if any, restrictions Gerald is under at the current time. He purchased shares only a few months back, but a lot has happened since then. If we follow his comments during recent presentations, there are a number of aspects he can't comment on. It's very possible those negotiations now extend to his ability to purchase shares, particularly in light of SEC regulations restricting insider trading activity during such negotiations.
Just because he makes an off-mic comment that "he'd be buying all he can at 8 cents" doesn't translate into that being a lie or trying to mislead anyone. He has clearly demonstrated over the last several years his faith in the company buy purchases shares with his own money, in addition to the shares awarded him for his work as CEO.
You might ask the question why doesn't Warp purchase shares under 8 cents if he believes so strongly in the company. I assure you, I really would like to, but I have other obligations, namely the IRS to deal with, given my large Roth conversion done in 2013, and prudence dictates I address the tax bill associated with that with every spare dollar I generate, rather than buy more shares when I already own a ton at a very low cost basis. I am demonstrating my solid faith in the company by locking in the conversion (as well as the resulting tax bill). Once I work through that with paying from wages, I'll certainly be back to buying more shares.
There are reasons for every decision to act or not to act. You're making speculations without having all the facts. Claiming Gerald is misleading us or is demonstrating lack of character by not following his own advice is pretty petty, especially when one is operating without the facts.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...
Continue Reading
A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...
Continue Reading
A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...
Continue Reading
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...
Continue Reading
In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...
Continue Reading
A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...
Continue Reading
Executive Shake-Up Aims for Stronger Federal Market Alignment Buckle up, folks—there's some major chess-piecing happening at Quantum Sky. They've just named not one or two, but three executive bigwigs to head up their core business groups. This isn’t just some ceremonial reshuffle. Nah, it’s bigger. They're redefining how they tackle the Department of War, Intel &...
Continue Reading
Top 5 Most Recently Viewed Articles
Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...
Continue Reading
Understanding HCA Healthcare's Investment Performance HCA Healthcare (NYSE: HCA) has shown remarkable growth over the past five years, outpacing the market with an annualized return of 22.56%. This performance highlights the significant returns that can be achieved through strategic investments in healthcare services. With a market capitalization of $88.18 billion, HCA...
Continue Reading
Unlocking the Potential of Home Bancorp’s Earnings Home Bancorp (NASDAQ: HBCP) is preparing to share its quarterly earnings. Investors are keenly waiting as the announcement approaches, hoping for insights that might influence their investment strategies. Analysts predict that Home Bancorp will report an earnings per share (EPS) of $0.99. This figure is pivotal as...
Continue Reading
Introducing PostcardMania's New Automated Mailer Products PostcardMania, a key player in the marketing technology industry, has recently gained attention by unveiling two groundbreaking fully automated mailer products. These innovative tools are designed to boost targeted marketing efforts by directly connecting businesses with potential customers through specially...
Continue Reading
Pharming Group's Remarkable Shift to the AMX Index Pharming Group N.V. is making waves in the biopharmaceutical sector as it moves from the Euronext AScX® to the AMX® index. This change, effective soon, not only signifies the company’s solid growth trajectory but also enhances its visibility among investors. With so many developments, Pharming is poised to capitalize...
Continue Reading
